BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2014

Position Statistics

Total Positions 78
New Positions 9
Increased Positions 36
Decreased Positions 25
Positions with Activity 61
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,432

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.62%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.32%
Healthcare 87.15%
Services 0%
Technology
Transportation
Utilities

36 INCREASED Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
MEDGENICS INC COM NEW 9,194 9,194 New 1,025,000
CATALYST PHARM PARTNERS INC COM 8,856 3,690 71.43 2,400,000
FLEXION THERAPEUTICS INC COM 7,653 3,704 93.81 413,204
PARATEK PHARMACEUTICALS INC COM 7,514 7,514 New 260,283
ACCURAY INC COM 6,381 1,823 40 700,000
IGNYTA INC COM 6,045 3,925 185.20 641,700
AMARIN CORP PLC SPONS ADR NEW 5,205 5,205 New 2,233,746
AQUINOX PHARMACEUTICALS INC COM 4,132 165 4.17 531,768
HEARTWARE INTL INC COM 3,940 3,940 New 50,000
CARDICA INC COM 3,772 .01 8,874,992
NOVADAQ TECHNOLOGIES INC COM 3,693 1,380 59.68 311,403
ADMA BIOLOGICS INC COM 3,503 3,503 New 389,193
ONCOTHYREON INC COM 3,480 870 33.33 2,000,000
MASIMO CORP COM 3,410 3,410 New 97,900
TONIX PHARMACEUTICALS HLDG COR COM NEW 3,271 1,469 81.49 501,639
RAPTOR PHARMACEUTICAL CORP COM 168 168 New 15,558


Create your free portfolio